To access premium content, including our discussion forum, register on AJP.com.au during September for your chance to WIN one of three 12-month subscriptions to eMIMS
Each single user annual subscription is for eMIMSCloud and the IMGateway drug, herb, food and supplement interactions data base, and is valued at $404.05 per subscription.
Still recommended text by the Pharmacy Board of Australia. The content in eMIMSCloud includes current Australian Product and Consumer Medicine Information, up-to-date PBS restrictions and pricing and a comprehensive evidence-based drug to drug and drug to allergy Interactions database. With additional links to TGA safety bulletins, NPS RADAR and NPS Medicines Update articles; eMIMS is one of MIMS’ richest resources, placing current medicines information, patient care information and clinical tools at your fingertips.
In the new eMIMSCloud you will find additional content such as tools and calculators to help you make decisions based on evidence based parameters.
The IMgateway Drug Herb and Food and Supplement interaction database is a unique interactions data base developed by Sydney University, School of Pharmacy and is an ideal resource for Pharmacists. The IMgateway database is continually evolving and growing in the number of evidence based interactions reported and enables pharmacists to retrieve evidence-based information on clinically-significant drug and herb interactions, drug and food interactions and now drug and Traditional Chinese Medicines (TMC) and Japanese Kampo Medicines interactions.
So register in September for AJP.com.au to gain full access to our news, analysis, discussion and education offerings AND have the chance to win one of these valuable MIMS subscriptions